Effect of Amnion Membrane With and Without Taurine on GCF TNF α Level.

• Status: Completed
• Trial end date: 2021-03-13
• Target enrollment: 0
• Participant gender: All

Summary

45 sites in 15 patients with periodontal pockets ≥ 5mm were selected. These selected sites were divided into 3 groups as Group A, B and C.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Maharishi Markendeswar University (Deemed to be University)

Criteria

Inclusion Criteria:

•Systemically healthy patients with sites showing probing depth (PD) ≥ 5mm, clinical attachment level (CAL) ≥ 4 mm, and vertical bone loss ≥ 3 mm on intraoral periapical radiographs with no history of periodontal therapy or use of antibiotics in the preceding 6 months

Exclusion Criteria:

• Any systemic disease that could influence the outcome of periodontal therapy.

• Smokers, alcoholics & patients with other adverse habits.

• Pregnant or nursing women.

• Any known allergy or hypersensitivity to any product used in the study.

• Patients on long term systemic therapy (antibiotics, anti-inflammatory and any other).